The Newbury of Brookline Launches Respite Care Program to Support Boston-Area Seniors and Their Caregivers
The Newbury of Brookline, a Kisco Senior Living community, has announced the launch of a respite care program aimed at supporting Boston-area seniors and their caregivers. This program offers temporary accommodations, personalized care, chef-prepared meals tailored to various dietary needs, and a comprehensive schedule of life-enriching activities. Among the innovative offerings is the Tovertafel, an interactive game projection system that supports social, physical, sensory, and cognitive wellbeing.
Frances Bates, general manager at The Newbury of Brookline, highlighted the significance of the program for adult children caring for their parents. With caregiver stress being a pressing issue in the U.S., where over 11 million Americans provide unpaid care for individuals with dementia, the respite program serves as a vital resource. It allows caregivers to take necessary breaks, knowing their loved ones are in a safe and nurturing environment.
The introduction of this program addresses a critical need in the community, as studies indicate that 70% of caregivers find coordinating care to be highly stressful. By offering a solution that combines quality care for seniors with much-needed relief for caregivers, The Newbury of Brookline is setting a new standard in senior living and care services.
This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp
. The source URL for this press release is The Newbury of Brookline Launches Respite Care Program to Support Boston-Area Seniors and Their Caregivers.
More From Montreal Breaking
Blerina Limaj Joins Peapack Private to Lead NY...
Peapack-Gladstone Financial Corporation and Peapack Private Bank & Trust have announced the addition of Blerina...
Harford Schools Lead Legal Battle Against Social Media...
Harford County’s Board of Education is set to be among the first to trial in...
Lexaria’s DehydraTECH-Semaglutide Shows Significant Reduction in Side Effects...
Lexaria Bioscience Corp. has released promising interim results from its phase 1b study, GLP-1-H24-4, showcasing...
Dutch Startup Innovates with Rapid Field Test for...
Spotlight Diagnostics, a startup from Eindhoven, Netherlands, is pioneering a portable test kit designed to...